Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02255240
Other study ID # 14-0240
Secondary ID 1K07CA175141-01A
Status Withdrawn
Phase N/A
First received September 29, 2014
Last updated May 26, 2015
Start date September 2014
Est. completion date January 2015

Study information

Verified date September 2014
Source The University of Texas Medical Branch, Galveston
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test an intervention that uses home console video games to encourage increased physical activity among postmenopausal breast cancer survivors.


Description:

This research project includes qualitative and quantitative formative research leading to a randomized controlled feasibility trial of a video game-based physical activity intervention. First, we will investigate exercise protocols implemented over 6 weeks in 20 breast cancer survivors. We will choose a console and six games for inclusion in the trial, based on measured energy expenditure and enjoyment. We will create refined exercise protocols using these games and insights from participants. Second, we will test an intervention that uses active video games for implementation of motivating exercise and provision of behavioral tools (e.g., tracking of progress towards goals). Participants in a pre-pilot trial (N = 10) will receive weekly brief telephone counseling over 6 weeks. Feasibility measurement will include attrition, self-reported acceptability, and objective measures of video game play taken from game console data.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date January 2015
Est. primary completion date January 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 45 Years to 75 Years
Eligibility Inclusion Criteria:

- Female

- Aged 45 - 75

- Diagnosed with breast cancer within the past 10 years

Exclusion Criteria:

- Chemotherapy or radiation treatment in the past six months

- Surgery in the past six months

- Evidence of disease recurrence

- Unable to read and understand English

- Unable to see a TV screen from several feet away

- Unable to find transportation to the study location

- No Internet access in the home (only for intervention portion of the study)

- Participant is active (60 minutes of moderate-vigorous intensity activity per week or more)

- BMI is under 18.5 kg/m2 or over 40 kg/m2

- Participant reports psychological issues that would interfere with study completion. Examples will be provided to illustrate potential psychological issues, such as dementia or schizophrenia.

- Inadequate performance on Senior Fitness Test, indicating inability to engage in video game exercise procedures (total score < 9 out of 12)

- Report a heart condition, chest pain during periods of activity or rest, loss of consciousness, etc. on the Physical Activity Readiness Questionnaire (PAR-Q), unless cleared by their physician

- Unable to walk, jump, and jog as may be required by some games (self-report)

- Report current symptoms of alcohol or substance dependence

- Plans to move away from the Galveston-Houston area or to be out of town for more than 1 week during the study period

- Unwillingness to report drugs taken for comorbidities such as hypertension or diabetes

- Stroke, hip fracture, hip or knee replacement, or spinal surgery in the past 6 months

- Report a history of orthopedic complications that would prevent optimal participation in the physical activities prescribed (e.g., heel spurs, severe arthritis)

- Clinical judgment concerning safety

- Currently participating in a physical activity or weight program/research study

- Currently pregnant or nursing

- No TV is available in the participant's home

- Currently on a weight loss diet or has lost more than 5% body weight in the previous 6 months

- Current smoker

- Game console to be used in the study is already available in the home

- Another member of the household is a participant or staff member on this trial

Study Design

Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Behavioral:
Physical activity intervention
Participants will receive counseling on self-regulatory skill building that has been adapted to complement the video games used. We anticipate that the games used will consist of fitness, sports, and dance games and will be played on a Wii U console. The games played will be chosen by each participant from a pool of potential appropriate games.

Locations

Country Name City State
United States University of Texas Medical Branch Galveston Texas

Sponsors (2)

Lead Sponsor Collaborator
The University of Texas Medical Branch, Galveston National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Number of participants who drop out of the study from baseline to 6 weeks We will investigate the number of participants who drop out of the intervention group in comparison to similar studies 6 weeks No
Other Acceptability We will measure acceptability of the intervention components and tools using validated self-report measures and qualitative interviews/focus groups 6 weeks No
Other Number of participants who report adverse events We will inquire about potential adverse events during counseling calls and assessment visits. Discrete events will be summed, and the number of participants with events will be summed. 6 weeks Yes
Other Adherence We will use objective measures to investigate adherence to game play protocols (console logs, automatic postings to the console social network, etc.) 6 weeks No
Primary Change in physical activity from baseline to 6 weeks Minutes of moderate-vigorous physical activity measured over a 7 day period 6 weeks No
Secondary Change in physical fitness from baseline to 6 weeks We will use a six minute walk test to measure fitness 6 weeks No
Secondary Change in weight from baseline to 6 weeks Weight will be measured using a calibrated scale 6 weeks No
Secondary Change in motivation from baseline to 6 weeks We will measure autonomous motivation (intrinsic, integrated, identified, etc.) specific to physical activity 6 weeks No
Secondary Change in body function from baseline to 6 weeks We will use the Senior Fitness Test to measure strength and body function 6 weeks No
Secondary Change in quality of life from baseline to 6 weeks We will use the Functional Assessment of Cancer Therapy - Breast measure to quantify quality of life 6 weeks No
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Recruiting NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2